Evidence map›Paper›PMID 32692291›Full record

ArticleThe Journal of international medical research2020

Pretargeted radioimmunoimaging with a biotinylated D-D

Zhihui Hong, Shengming Deng, Yizhen Shi, Yichi Xie, Jiaxi You, Wei Wang, Hong Huang, Zengli Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhihui HongDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.ORCID https://orcid.org/0000-0002-1450-7721
Shengming DengDepartment of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Yizhen ShiDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Yichi XieDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Jiaxi YouDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Wei WangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Hong HuangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Zengli LiuDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, P. R China.
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePro-gastrin releasing peptide (ProGRP) plays an oncogenic role in small cell lung cancer (SCLC). The anti-ProGRP

methodsD-D

results

conclusionsIn contrast to directly labeled D-D

Indexed as

Lung NeoplasmsSmall Cell Lung CarcinomaAnimalsBiotinEarly Detection of CancerMiceMice, NudeRadioimmunodetectionRadiopharmaceuticalsTechnetiumTechnetium Tc 99m PentetateTissue DistributionBiotinRadiopharmaceuticalsTechnetiumTechnetium Tc 99m PentetatebiodistributionBiotin-avidinmonoclonal antibody D-D3ProGRP(31-98)radioimmunoimagingsmall cell lung cancer

Identifiers

PMID32692291
PMCPMC7375734
OpenAlexW3045166450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.